Clinical trial
A Phase 2, Double-blind, Randomized, Placebo-controlled Multicenter Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of JBT-101 in Cystic Fibrosis
NCT02465450 is registered in ClinicalTrials.gov with Corbus Pharmaceuticals Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2, Double-blind, Randomized, Placebo-controlled Multicenter Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of JBT-101 in Cystic Fibrosis
- Lead sponsor
- Corbus Pharmaceuticals Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 29, 2015
- Completion date
- December 28, 2016
- Enrollment
- 85 (actual)
- Sites
- 27
Conditions
As the registry lists them; a condition with its own page is linked.